-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
BioMarin Announces Board Leadership Transition
-
-
-
-
-
-
-
Bitcoin slump shakes companies that jumped on crypto-hoarding bandwagon
-
-
-
-
-
-
-
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Announces Completion of Acquisition of Inozyme (INZY)
-
-
-
-
-
-
-
BioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ET
-
-
-
-
-
-
-
BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET
-
1,219,416 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

